interleukin 23
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started May 1, 2025 (NCT06713187)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Interleukin-23 subunit alphaSupplementation
IL23A supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07216014 | Phase 4 | Dec 1, 2025 | Sun Yat-Sen University |
| NCT06713187 | N/A | May 1, 2025 | Sohag University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sohag University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1